AEON Biopharma Stock Quote AEON - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.5636

Bid

Ask

Volume

0.00 Day's Range 0.00

0.55 52 Week Range 17.17

Market Cap

22.527M

Previous Close

0.5636

Open

Last Trade

0.5702

Last Trade Time

06:45:44

Financial Volume

VWAP

Average Volume (3m)

141,293

Shares Outstanding

39,970,693

Dividend Yield

PE Ratio

0.93

Earnings Per Share (EPS)

0.6

Revenue

52.75M

Net Profit

24.05M

AEON Biopharma, Inc. is a bio-pharmaceutical company. The Company is focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions with an initial focus on the neurology and gastroenterology markets. ABP-450 contains a 900 kDa botulinum toxin type-... AEON Biopharma, Inc. is a bio-pharmaceutical company. The Company is focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions with an initial focus on the neurology and gastroenterology markets. ABP-450 contains a 900 kDa botulinum toxin type-A complex produced by the bacterium clostridium botulinum. The active part of the botulinum toxin is the 150 kDa component, and the remaining 750 kDa of the complex is made up of accessory proteins. When injected at therapeutic levels, ABP-450 blocks peripheral acetylcholine release at presynaptic cholinergic nerve terminals by cleaving SNAP-25, a protein integral to the docking and release of acetylcholine from vesicles situated within the nerve endings leading to denervation and relaxation of the muscle. It is also engaged in the Phase II clinical study of ABP-450 for the treatment of cervical dystonia. Cervical dystonia, also known as spasmodic torticollis, is a neurological condition. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Headquarters

Wilmington, Delaware, USA

Founded

2022

AEON Biopharma Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker AEON. The last closing price for AEON Biopharma was $0.56. Over the last year, AEON Biopharma shares have traded in a share price range of $ 0.55 to $ 17.17.

AEON Biopharma currently has 39,970,693 shares outstanding. The market capitalization of AEON Biopharma is $22.53 million. AEON Biopharma has a price to earnings ratio (PE ratio) of 0.93.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1364	-19.4857142857	0.7	0.708	0.55	149372	0.59718112	CS
4	-0.4164	-42.4897959184	0.98	1.03	0.55	114045	0.75880226	CS
12	-0.3801	-40.2776306029	0.9437	1.6051	0.55	141293	0.96231792	CS
26	-1.0864	-65.8424242424	1.65	3.74	0.55	911346	2.33076827	CS
52	-4.2964	-88.4032921811	4.86	17.17	0.55	490271	2.61345919	CS
156	-9.5764	-94.4418145957	10.14	17.17	0.55	388642	2.8173372	CS
260	-9.5764	-94.4418145957	10.14	17.17	0.55	388642	2.8173372	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BBLUEa Bridgeway Blue Chip ETF	$ 17.50 (32.98%)	1
EBNDSPDR Bloomberg Emerging Markets Local Bond ETF	$ 25.00 (25.38%)	3
GENCGencor Industries Inc	$ 25.99 (21.85%)	4
SNOYYieldmax Snow Option Income Strategy ETF	$ 20.83 (18.62%)	464
MSTUT Rex 2X Long MSTR Daily Target ETF	$ 300.50 (17.05%)	839.82k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	$ 0.6548 (-19.44%)	32.82M
ETHDProshares Ultrashort Ether ETF	$ 26.50 (-15.71%)	9.73k
EVBNEvans Bancorp Inc	$ 37.00 (-12.96%)	3
OGENOragenics Inc	$ 0.2601 (-9.69%)	170
ETQT Rex 2X Inverse Ether Daily Target ETF	$ 12.80 (-9.31%)	1
MSTZT Rex 2X Inverse MSTR Daily Target ETF	$ 0.6548 (-19.44%)	32.82M
ETHU2x Ether ETF	$ 8.62 (16.64%)	5.96M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	$ 3.11 (1.63%)	4.26M
SOXLDirexion Daily Semiconductor Bull 3X Shares	$ 26.91 (-0.81%)	4.18M
SOXSDirexion Daily Semiconductor Bear 3X Shares New	$ 24.85 (0.89%)	1.81M